GLISEN SM 1MG (Sitagliptin (50mg) + Glimepiride (1mg) + Metformin (1000mg))

Glisen SM 1 Tablet is a medication that combines three active ingredients designed to help manage blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. This medication is typically prescribed when lifestyle changes, such as diet and exercise, or other diabetes treatments fail to achieve satisfactory blood sugar control. For optimal results, it is recommended to take Glisen SM 1 Tablet with food and at consistent times each day. The prescribing physician will determine the appropriate dosage and treatment duration based on the patient’s medical condition and response to therapy. Regular monitoring of blood glucose levels may be necessary while on this combination therapy. It is important to continue taking this medication even if blood sugar levels appear to be stable or the patient feels well, as discontinuing it suddenly could lead to a significant increase in blood glucose, posing potential health risks. This treatment should be part of a broader diabetes management plan encompassing a balanced diet, physical activity, and weight management, reflecting the significant role of lifestyle factors in diabetic care. Patients with type 1 diabetes or certain metabolic disorders should avoid this medication. Additionally, those with current or past bladder cancer should refrain from using Glisen SM 1 Tablet. It’s crucial to inform healthcare providers of all other medications being taken, as interactions may occur. Pregnant and breastfeeding individuals should seek medical advice prior to starting this medication.